Post-IPO Equity Biotechnology Companies

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

VolitionRx develops easy to use blood-based cancer tests to accurately diagnose a range of cancers.

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.

ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

Polaryx Therapeutics is a biopharmaceutical company that provides molecule therapeutics development and clinical trial services.

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

MustGrow Biologics is an agriculture biotech company providing natural, science-based biological solutions for crops.

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies.

Immix Biopharma is a biotech company that develops treatments for cancer and other inflammation-driven diseases.

Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.

NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.

Jupiter Neurosciences is a biotechnology company that focuses on developing a treatment for Alzheimer and rare neurological disorders.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Zentek is a nanomaterials technology company that develops graphene-based technologies.

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease